Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Tetanus
  4. Tetanus Information For Health Professionals
Topic Menu

Tetanus

  • Tetanus Home
  • Basics
  • For Health Professionals
  • Statistics

Related Topics

  • Immunization
  • Diphtheria
  • Pertussis (Whooping Cough)
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases

Tetanus

  • Tetanus Home
  • Basics
  • For Health Professionals
  • Statistics

Related Topics

  • Immunization
  • Diphtheria
  • Pertussis (Whooping Cough)
  • Infectious Diseases A-Z
  • Reportable Infectious Diseases
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Summary Guide to Tetanus Prophylaxis in Routine Wound Management

A summary guide to examining wounds for possible tetanus prophylaxis.

PDF version formatted for print: Summary Guide to Tetanus Prophylaxis in Routine Wound Management (PDF)


Summary guide to tetanus prophylaxis in routine wound management flow chart.


  1. Primary series: A minimum of three doses of tetanus toxoid-containing vaccine (Tdap, DTaP or Td). Persons with unknown or uncertain tetanus vaccination history should be considered not vaccinated.
  2. Age-appropriate vaccine: Infants or children under 7 years of age: DTaP (or Td if pertussis component is contraindicated).
    • Persons 7 years of age and older: Td is acceptable for routine 10-year boosters or catch-up vaccination.
      • Tdap is preferred as the first dose for those 11 years of age and older who have not previously received Tdap.
      • If Tdap has been given previously and another tetanus toxoid-containing dose is indicated (nonpregnant), either Td or Tdap may be used.
    • Pregnancy: If a tetanus toxoid-containing dose is indicated, Tdap should be used.
  3. Tetanus immune globulin (TIG):
    • Dose: 250 U IM for all ages when indicated.
    • Administration: If both TIG and vaccine are required, give simultaneously in separate syringes and at different anatomical sites.
    • Indications (give TIG in the following situations):
      • Persons with less than three documented doses of tetanus toxoid–containing vaccine, or with unknown vaccination history, who present with contaminated wounds.
      • Infants less than 6 weeks of age with contaminated wounds (no vaccine is licensed at this age; give TIG only).
      • Infants over 6 weeks of age who have received only one prior DTaP dose less than 4 weeks earlier and present with a contaminated wound. Give TIG now for immediate protection and defer the second DTaP dose until 4 weeks or more after the first dose so it is valid and can contribute to long-term immunity.
    • Persons with HIV infection or severe immunodeficiency who present with contaminated wounds; give TIG regardless of prior tetanus vaccination history.
  4. Already protected: Persons who have completed a primary series of tetanus toxoid-containing vaccine AND received one dose of tetanus toxoid-containing vaccine within the past five years, do not require vaccine or TIG for wound management.
  5. Timing:
    • Clean or minor wounds: Booster dose of tetanus toxoid-containing vaccine if less than 10 years since last dose.
    • All other wounds (contaminated): Booster dose of tetanus toxoid-containing vaccine if 5 years or more since last dose.
  6. Arthus reaction: Persons with a history of an Arthus reaction after a tetanus toxoid–containing vaccine should not receive another tetanus-toxoid–containing vaccine until more than 10 years after the most recent dose, regardless of wound type.
Tags
  • tetanus
Last Updated: 09/17/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube